Traws Pharma, Inc. · NASDAQ:TRAW
Adage Capital Management, L.P.'s stake in Traws Pharma, Inc. fell to 4.79% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 12, 2026
Adage Capital Management, L.P.'s stake in Traws Pharma, Inc. fell to 4.79%, 730,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).
- Stake
- 4.79%
- Shares
- 730,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 4.79% | 730,000 |
| Robert Atchinson | 4.79% | 730,000 |
| Phillip Gross | 4.79% | 730,000 |
Source
Related
- Traws Pharma, Inc.
- Adage Capital Management, L.P.
- Traws Pharma, Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · May 12, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026